Wellington Management Group LLP 13D and 13G filings for Agios Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-09 1:26 pm Sale |
2023-10-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Wellington Management Group LLP | 2,200,757 3.950% |
-3,522,374 (-61.55%) |
Filing |
| 2023-04-10 09:06 am Purchase |
2023-03-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Wellington Management Group LLP | 5,723,131 10.350% |
260,474 (+4.77%) |
Filing |
| 2023-02-06 2:43 pm Purchase |
2022-12-30 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Wellington Management Group LLP | 5,462,657 9.940% |
314,091 (+6.10%) |
Filing |
| 2022-02-04 09:12 am Sale |
2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Wellington Management Group LLP | 5,148,566 9.480% |
-2,728,804 (-34.64%) |
Filing |
| 2021-02-03 1:22 pm Sale |
2020-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO |
Wellington Management Group LLP | 7,877,370 11.370% |
-98,453 (-1.23%) |
Filing |